[1]
S., M. and Kumar M., K. 2024. Expert opinion on the prescription practice of silodosin for treating benign prostatic hyperplasia patients in Indian clinical settings. International Journal of Advances in Medicine. 11, 2 (Feb. 2024), 94–98. DOI:https://doi.org/10.18203/2349-3933.ijam20240360.